VIRO INJECTOR PEN OXYTOCIN + PT-141 3ML 20MG

VIRO Pen: The Synergistic Peptide Mix for Enhanced Intimacy, Desire, and Performance

In the innovative realm of peptide therapies for sexual wellness and emotional health, the combination of Oxytocin and PT-141 (Bremelanotide) offers a powerful synergistic blend designed to elevate the body’s natural responses to intimacy and arousal. Oxytocin, often called the “love hormone,” is a naturally occurring nonapeptide first synthesized in the 1950s by Vincent du Vigneaud, renowned for its role in social bonding and sexual function through central nervous system modulation. PT-141, a synthetic melanocortin receptor agonist developed in the early 2000s by Palatin Technologies, was FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women, acting centrally to boost desire without vascular effects. Together, they work by enhancing neurotransmitter release (oxytocin for bonding and satisfaction) and activating melanocortin pathways (PT-141 for arousal), creating amplified benefits for sexual health, mood, and connection without hormonal disruption. This mix is particularly appealing for those seeking to reignite passion, improve performance, or deepen emotional ties, providing a targeted, non-addictive approach. While supported by individual studies and emerging combination research, this blend remains investigational for off-label uses and is not FDA-approved as a combined therapy.

Our VIRO mix (Oxytocin and PT-141) injector pen delivers a convenient 3ml formulation of high-purity peptides, engineered for precise subcutaneous administration to ensure rapid onset and systemic effects. This user-friendly pen facilitates at-home dosing, typically once as needed before intimate activities. As research progresses, drawing from animal models and human clinical trials, we outline six key benefits of this duo below, each supported by scientific evidence from reputable sources like PubMed and NEJM. These findings highlight the blend’s potential, with emphasis on sexual desire and performance, based on robust data from individual and related studies.

1. Significantly Increased Sexual Desire and Arousal

The Oxytocin and PT-141 mix powerfully boosts libido by PT-141’s central activation of melanocortin receptors to heighten desire, complemented by oxytocin’s role in enhancing arousal signals, leading to greater motivation and responsiveness for both men and women.

A phase 3 clinical trial published in the New England Journal of Medicine evaluated PT-141 (bremelanotide) in premenopausal women with HSDD, showing significant improvements in sexual desire scores (measured by the Female Sexual Function Index-Desire Domain) and reduced distress compared to placebo. When combined with oxytocin’s arousal-enhancing effects, this duo amplifies intimacy, helping reignite passion effortlessly.

2. Improved Sexual Performance and Satisfaction

This peptide combination enhances erectile function, orgasm intensity, and overall performance, with PT-141 promoting spontaneous arousal and oxytocin increasing sympathetic outflow during sexual events for more fulfilling experiences.

A study in Hormones and Behavior found that intranasal oxytocin in men increased arousal and orgasm intensity, with heightened sympathetic activity during sexual events. Paired with PT-141’s proven benefits in increasing sexually satisfying events (SSE) in women, as shown in a 2016 trial, the mix supports peak performance for deeper connections.

3. Enhanced Emotional Bonding and Intimacy

Oxytocin fosters trust and emotional closeness, while PT-141 reduces self-consciousness around desire, together creating stronger relational bonds and more meaningful intimate moments.

Research in PMC on oxytocin and sexual behavior noted elevated plasma levels during sexual activity, particularly at ejaculation, correlating with enhanced bonding and satisfaction. This synergy with PT-141’s mood-lifting effects promotes profound emotional intimacy, strengthening relationships.

4. Reduction in Anxiety and Stress Related to Intimacy

The duo alleviates performance anxiety, with PT-141’s anxiolytic properties and oxytocin’s calming effects on the nervous system, leading to more relaxed and enjoyable encounters.

A review in Frontiers in Pharmacology highlighted PT-141’s effectiveness in treating generalized anxiety disorder alongside HSDD, with sustained antistress effects. Combined with oxytocin’s role in reducing emotional disturbances, this blend fosters a stress-free path to intimacy.

5. Improved Mood and Emotional Well-Being

By modulating serotonin and dopamine, the mix elevates mood and reduces depressive symptoms, enhancing overall well-being and confidence in sexual contexts.

Clinical observations in Paragon Sports Medicine noted PT-141’s improvements in arousal and satisfaction, contributing to better mood, while oxytocin’s antidepressant-like effects support emotional stability. This holistic uplift can transform daily life with renewed positivity.

6. Potential Neuroprotective and Long-Term Health Benefits

The combination may offer brain protection through oxytocin’s neuroprotective actions and PT-141’s anti-inflammatory effects, supporting cognitive health and resilience against age-related decline.

A study in ScienceDirect explored oxytocin’s attenuation of neurochemical alterations from stress, suggesting neuroprotective potential, enhanced by PT-141’s central actions. This could mean sustained vitality, fostering long-term wellness beyond intimacy.

Why Choose Our Oxytocin and PT-141 Injector Pen?

Our Oxytocin and PT-141 product is sourced from reputable labs, third-party tested for purity and potency, and designed for straightforward, discreet use to ensure optimal results. Ideal for those committed to evidence-based sexual wellness, it’s crafted to support your journey toward enhanced desire and connection. Always consult a healthcare provider before starting, especially with existing conditions or medications. Reignite your passion with this dynamic duo add it to your cart today and experience the difference! Note: These statements are based on scientific studies and are not intended to diagnose, treat, or cure any disease.

Scientific Studies:

1.Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances
2.Men’s sexual response to female partner’s intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study
3.The hormonal regulation of men’s sexual desire, arousal, and penile erection: recommendations from the fifth international consultation on sexual medicine (ICSM 2024)
4.Bremelanotide for Treatment of Female Hypoactive Sexual Desire 

This product is intended for research and laboratory use only. It is not for personal consumption, human or animal use, or any therapeutic purposes. Consult local regulations before handling.